SUMMARY The effects on coronary dynamics of propranolol and atenolol were studied in 12 patients undergoing cardiac catheterisation for suspected coronary artery disease. Myocardial blood flow was measured using the coronary sinus continuous thermodilution technique. Data were obtained immediately after drug administration and duringrapid atrial pacing. The immediate effects were similar for both drugs. A significant reduction in heart rate was accompanied by a small reduction in myocardial oxygen consumption. Changes in coronary sinus flow induced by rapid pacing were closely related to changes in tension-time index. This relation was not modified by propranolol or atenolol. Neither propranolol nor atenolol therefore has significant coronary vasoconstrictor properties. Cardioselectivity appears to be unimportant with respect to beta-adrenergic blockade and the coronary circulation.
The presence of alpha and beta-adrenergic receptors in the coronary vasculature of the dog has been shown (Parratt, 1965; Klocke et al., 1965; Gaal et al., 1966) . Furthermore, there is evidence that selective beta-adrenergic blockade of the dog heart spares the beta-adrenergic receptors of the coronary vessels (Ross and Jorgensen, 1968; Bussmann et al., 1970) suggesting that, like peripheral arterial systems, the coronary vasculature possesses socalled beta2-adrenergic receptors. As a vasoconstrictive effect of non-selective beta-adrenergic blockade has been shown in animals (Parratt and Grayson, 1966) and in man (Wolfson et al., 1966; Wolfson and Gorlin, 1969) , presumably because of unopposed alpha-adrenergic vasoconstrictor activity, it appears that the use of a selective beta 1-blocking agent would be more appropriate in the treatment of angina pectoris.
Atenolol ('Tenormin')-4(2-hydroxy-3-isopropylaminopropoxy-phenylacetamide) has been shown to possess a significant degree of cardio-selectivity in animals (Barrett et al., 1973) and in man (Marlin et al., 1975) . This drug was, therefore, compared with propranolol, a non-selective beta-adrenergic blocking drug with similar potency.
Received for publication 25 July 1977 Patients and methods Twelve patients undergoing cardiac catheterisation for suspected coronary artery disease were studied. The 11 men and 1 woman, from whom informed consent was obtained, received 10 mg diazepam as premedication. All other medication was discontinued 48 hours before the study. There was no evidence of cardiac failure, obstructive airways disease, bradycardia, renal or hepatic failure, or cardiac conduction disturbance.
After left ventriculography and coronary arteriography (Seldinger technique from the femoral artery) a No. 5 Desilet-HofEman cannula was placed in the femoral artery for arterial pressure monitoring and blood sampling. A Ganz thermodilution coronary sinus catheter with pacing electrodes was advanced to the coronary sinus via a left antecubital vein. Myocardial blood flow was determined by the method described by Ganz . These authors showed a good correlation between this and other standard methods. Coronary sinus flow is determined by a continuous thermodilution technique. The coronary sinus drains nearly all of the left ventricular myocardium (Hood, 1968) and coronary sinus flow may, therefore, be assumed to represent mainly left ventricular myocardial blood flow. To make this determination, 856 an injectate (5% dextrose) is delivered through an orifice near the tip of the catheter by a constant rate infusion pump. The temperature of the injectate is determined by a thermistor at the orifice, while that of the mixture of blood and injectate is determined by a proximally situated thermistor. Coronary sinus flow is calculated by a heat exchange formula described below. In an attempt to include the contribution to coronary sinus flow by the posterior interventricular vein which joins the coronary sinus near its orifice, close approximation of the proximal thermistor marker to the coronary sinus orifice was ensured by injection of contrast medium, before each determination. Blood samples were obtained through this catheter. Atropine 06 mg intravenously was administered to prevent possible vagal interactions (Glick and Braunwald, 1965) . Arterial pressure was measured using a Bell and Howell transducer. Leads II and V5 of the electrocardiogram were recorded. Recording was by Elema Mingograf 82.
Blood oxygen contents were derived from oxygen saturations measured spectrophotometrically (IL CO oximeter). This method was first calibrated against the fuel-cell technique (Lex-02-Con) which has been found to give results in close agreement with those obtained using the manometric technique of Van Slyke (Valeri et al., 1972; Adams and Cole, 1975) .
Rapid atrial pacing has been shown to produce increases in coronary sinus flow in patients with and without coronary artery disease (MacLeod et al., 1973) . Incremental increases in heart rate by pacing produce an identical linear response in normal subjects and in those with coronary artery disease to the point of development of angina . Rapid atrial pacing was, therefore, used in this study as a technique for augmenting possible effects on the coronary vasculature of propranolol and atenolol, in patients with and without coronary artery disease.
After the elapse of at least 30 minutes from the time of left ventricular angiography, measurements of heart rate, systemic arterial pressure, and coronary sinus flow were made. Simultaneous arterial and coronary sinus blood samples were obtained for oxygen content estimation. The heart rate was then increased by pacing by increments of 10 beats a minute until the onset of angina (when the pacing rate was reduced until this symptom was alleviated), atrioventricular block, or ST-T changes on the electrocardiogram developed, or 150 beats/ minute (160 in one patient) was achieved. Measurements were then repeated. (In some patients additional measurements were made at lower pacing rates.) Pacing was then terminated. At 10 minutes control measurements were repeated after which 0-1 mg/kg propranolol or atenolol, randomly selected, was administered intravenously. Measurements were repeated at 10 minutes in sinus rhythm and with the heart rate paced at the rate immediately preceding administration of the drug. Further measurements were then made during rapid atrial pacing as before.
Mean left ventricular systolic pressure and systolic ejection period were derived from the arterial pressure trace (Mueller et al., 1974) .
CALCULATIONS
Tension-time index (mmHg -s/min)=mean left ventricular systolic pressure' x systolic ejection period' x heart rate Coronary sinus flow ml/min
where TM=temperature of mixture of blood and injectate,°C; T1=temperature of injectate,°C; TB=temperature of blood,°C; K=a constant relating specific heat and density of blood and injectate (1.08); and Qi=rate of infusion of injectate, ml/min (36 ml/min).
Myocardial oxygen consumption, ml/min=coro-nary sinus flow x coronary arteriovenous oxygen content (AV 02) difference.
DATA ANALYSIS
The data analysis was performed in the following way.
Comparisons between (a) before and after drug with heart rate free and with the heart paced to control rate after beta-blockade, (b) before and after drug during rapid atrial pacing.
(Statistical analysis by paired t test.) The relation between tension-time index and coronary sinus flow was examined by regression analysis.
Results

INITIAL HAEMODYNAMIC AND CINEANGIOGRAPHIC DATA
The left ventricular end-diastolic pressure and ejection fraction were normal in all patients. In 10 patients there was significant coronary artery disease while in 2 patients the coronary arteries were normal (Table 1) .
'Systolic ejection period was measured from the upstroke of the femoral artery pressure record to the dicrotic notch. The mean femoral arterial pressure during this period was taken as a measure of mean left ventricular systolic pressure. Table 3 . HR, heart rate (beats/min); MVO,, myocardial oxygen consumption (ml/min); TTI, tension-time index (mmHg-s/min); CSF, coronary sinus flow (ml/min); SEP, systolic ejection period (s); SEM, standard error of mean; AV°2 diff., coronary arteriovenous oxygen content difference (ml/100 ml); LVSP, mean left ventricular systolic pressure (mmHg); P, significance. Table 2 .
EFFECTS OF RESTORING HEART RATE in some patients after drug administration, preventWhen the heart rate was artificially restored to that ing the achievement of identical heart rates. Howimmediately preceding drug administration, systolic ever, where it was possible to compare data for ejection period and tension time index returned to identical heart rates no significant changes were control levels. Similar effects on coronary sinus observed after either drug except for a fall in mean flow and myocardial oxygen consumption were coronary sinus flow after propranolol (Tables 6 and  observed Fig. 2 and 3 . Table 2 . *Means, SEM, and significance given for these patients only. In the present study propranolol produced against tension-time index for individual patients a relatively small falls in coronary sinus flow without highly significant linear correlation was obtained significantly affecting the AV 02 difference. (Fig. 4 and 5) . Thus, values obtained before and Consequently there was a comparable fall in after either drug fell on the same regression line. myocardial oxygen consumption. Similar changes were observed with atenolol. As heart rate, a major Discussion determinant of myocardial oxygen consumption (Sarnoff et al., 1958) , fell significantly a greater fall The relatively few published reports concerning the in the latter may have been expected. However, it effects of propranolol on the coronary vasculature is seen that there is a simultaneous increase in the in man present a confusing picture. While a re-duration of systole, as previously observed (Sowton duction in myocardial blood flow associated with and Hamer, 1966) after propranolol. This tends to widening of the coronary AV 02 difference has been increase myocardial oxygen consumption (Sarnoff reported (Wolfson et al., 1966; Wolfson and et al., 1958) and thus offset the effect of heart rate Gorlin, 1969) suggesting a vasoconstrictor effect, reduction. Further, propranolol has been shown to others have shown reductions in myocardial blood increase left ventricular end-diastolic volume flow with narrowing of the coronary AV 02 dif- (Chamberlain, 1966; Helfant et al., 1971 ) and thus ference (Mueller et al., 1974) . Significant falls in myocardial wall tension; a change known to increase myocardial blood flow after propranolol administra-myocardial oxSgen consumption (Taylor et al., 1967;  tion were observed by Reale et al. (1970) in patients Graham et al., 1968) . In contrast, the reduction by with normal coronary arteries while Lewis and propranolol of myocardial contractility (Wolfson Brink (1968) found no change in mean myocardial et al., 1966; Lewis and Brink, 1968) group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from the opposite effect (Sonnenblick et al., 1965; Graham et al., 1968) .
It is clear, therefore, that the net effect of propranolol on myocardial oxygen consumption depends upon the relative prevailing influences of these separate variables. In this study the restoration of heart rate after beta-adrenergic blockade, with the consequent return to control levels of the systolic ejection period, cancelled the observed changes in myocardial oxygen consumption. This suggests that these variables are the major determinants of the net effect of these agents on myocardial oxygen consumption at rest. Since depression of contractility would be unaffected by the restoration of heart rate, it is unlikely that betaadrenergic blockade produced this effect to an important degree, since a persistent reduction of myocardial oxygen consumption would then be expected.
The increase in coronary sinus flow produced by rapid atrial pacing is probably in response to increased myocardial oxygen demand as a result of augmentation of the rate of left ventricular force development (Sonnenblick et al., 1966) . If propranolol causes coronary vasoconstriction, the appearance of a disparity between myocardial oxygen demand and supply would be expected. This would show as a reduction in myocardial blood flow or a widening of the coronary AV 02 difference, or a combination of both. However, a reduction in myocardial blood flow (myocardial oxygen supply) may result from a reduction in myocardial oxygen demand, since myocardial blood flow is controlled by an autoregulatory mechanism depending on local metabolites which influence coronary vascular tone (Berne, 1964) . Therefore, a reduction in myocardial blood flow after the administration of a given drug cannot per se be said to represent an inappropriate or non-physiological, coronary vasoconstrictive effect of that drug. In this study, it is seen that after propranolol, but not atenolol, there was a significant reduction in mean coronary sinus flow during rapid pacing. There was an accompanying fall not reaching statistical significance in mean myocardial oxygen consumption. It may be argued that this represents a direct, that is non-physiological vasoconstrictive effect of propranolol. To analyse these changes further, it is pertinent to examine the relation between myocardial oxygen demand and supply. The former has been shown to correlate closely with the tension-time index (Sarnoff et al., 1958) while the latter may be represented by coronary sinus flow as previously discussed. As can be seen in Fig. 4 Beta-adrenergic blocking drugs are used specifically in the resting patient with coronary artery disease: for example in certain patients with acute myocardial infarction, where a reduction in myocardial oxygen consumption is desired. The results of this study however suggest that the degree of such a reduction achieved by beta-adrenergic blockade may be modest. Thus, though beta-adrenergic blockade may for example effectively reduce heart rate in such patients a parallel reduction in myocardial oxygen consumption cannot necessarily be expected. It is probable that the more important role of such therapy is that of the prevention of tachycardia induced, for example, by emotional stress, since a rise in heart rate may result in significant augmentation of myocardial oxygen consumption.
Atenolol appears to possess similar coronary haemodynamic properties to those of propranolol. Its importance with respect to its cardioselectivity may, therefore, be confined to use in those patients with coronary artery disease who have coexisting obstructive airways disease. Conversely, its cardioselectivity with respect to the coronary and peripheral vasculature may become important in the exercising patient with angina pectoris when circulating catecholamine activity is augmented, since possible coronary or peripheral vasoconstrictive properties of propranolol may then become manifest. Such a possibility requires further investigation.
The relatively minor changes in coronary dynamics observed after beta-adrenergic blockade in this study suggest that a direct effect of these agents on the myocardium or coronary vasculature is unlikely to have therapeutic relevance in the ambulant patient with angina pectoris. It is probable that their importance in this respect lies solely in their ability to reduce the degree of exertional tachycardia and hence myocardial oxygen demand.
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